Avidity Biosciences Inc RNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
25.52UNCH (UNCH)
Volume
40,257
Close
25.52UNCH (UNCH)
Volume
1,191,692
52 week range
4.82 - 26.24
Loading...
  • Open24.56
  • Day High25.95
  • Day Low24.50
  • Prev Close24.67
  • 52 Week High26.24
  • 52 Week High Date03/14/24
  • 52 Week Low4.82
  • 52 Week Low Date10/31/23

Key Stats

  • Market Cap2.423B
  • Shares Out94.94M
  • 10 Day Average Volume1.44M
  • Dividend-
  • Dividend Yield-
  • Beta0.77
  • YTD % Change181.99

KEY STATS

  • Open24.56
  • Day High25.95
  • Day Low24.50
  • Prev Close24.67
  • 52 Week High26.24
  • 52 Week High Date03/14/24
  • 52 Week Low4.82
  • 52 Week Low Date10/31/23
  • Market Cap2.423B
  • Shares Out94.94M
  • 10 Day Average Volume1.44M
  • Dividend-
  • Dividend Yield-
  • Beta0.77
  • YTD % Change181.99

RATIOS/PROFITABILITY

  • EPS (TTM)-2.90
  • P/E (TTM)-8.79
  • Fwd P/E (NTM)-8.47
  • EBITDA (TTM)-233.454M
  • ROE (TTM)-39.34%
  • Revenue (TTM)9.56M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-2,219.88%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Avidity Biosciences Inc

 

Profile

MORE
Avidity Biosciences, Inc. is a biopharmaceutical company. The Company is engaged in delivering a new class of ribonucleic acid (RNA) therapeutics called antibody oligonucleotide conjugates (AOCs). The AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to address targets and diseases previously unreachable with existing RNA therapies. Its advancing and expanding pipeline has three programs in clinical...
Troy Wilson J.D., Ph.D.
Chairman of the Board
Sarah Boyce
President, Chief Executive Officer, Director
Michael Maclean
Chief Financial and Chief Business Officer
W. Michael Flanagan Ph.D.
Chief Scientific and Technical Officer
Address
10578 SCIENCE CENTER DRIVE, SUITE 125
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
CLDX
Celldex Therapeutics Inc
41.97UNCHUNCH
DYN
Dyne Therapeutics Inc
28.39UNCHUNCH
KROS
Keros Therapeutics Inc
66.20UNCHUNCH
JANX
Janux Therapeutics Inc
37.65UNCHUNCH
RCKT
Rocket Pharmaceuticals Inc
26.94UNCHUNCH